{
    "subject": "Effects on clinical relapses",
    "data": {
        "description": "return of a disease or the signs and symptoms of a disease after a period of improvement",
        "keywords": [
            "DMD",
            "tolerability",
            "natalizumab",
            "reduced",
            "IFNB-1b",
            "GA"
        ]
    }
}